會議議程

2022/8/14, 星期日

• 12:10~13:00
• Lunch symposium-台灣百健 A Hall
• A Hall (第一會議室) 2F

• Time
• Topic
• Speaker
• Moderator

• 12:10~12:15
• Welcome and Opening
• Speaker:  王署君
• Moderator: 

• 12:15~12:25
• The evolving of SMA treatment: Now and the Future
• Speaker:  翁妏謹
• Moderator:  王署君

• 12:25~12:55
• Panel discussion
• Speaker:  林恭平  /  蔡力凱  /  簡穎秀  /  翁妏謹
• Moderator:  王署君

• 12:55~13:00
• Closing & Take Home Message
• Speaker:  王署君
• Moderator: 

2022/8/14, 星期日

• 13:00~13:50
• Lunch symposium-賽諾菲 A Hall
• A Hall (第一會議室) 2F

• Time
• Topic
• Speaker
• Moderator

• 13:00 -13:05
• Welcome & Introductio
• Speaker:  李宜中
• Moderator: 

• 13:05 - 13:35
• Optimizing Outcomes in NMD: Exploring the Impact of Early Diagnosis and Next Generation Medicine in Pompe
• Speaker:  Robert Henderson
• Moderator:  李宜中

• 13:35 - 13:45
• Q&A
• Speaker:  李宜中
• Moderator: 

• 13:45 - 13:50
• Closing Remarks
• Speaker:  李宜中
• Moderator: 

2022/8/14, 星期日

• 12:10~13:00
• Lunch symposium-衛采 B Hall
• B Hall (第二會議室) 1F

• Time
• Topic
• Speaker
• Moderator

• 12:10~12:15
• Opening
• Speaker:  林祖功
• Moderator: 

• 12:15~12:50
• Dual Actions of Mechanism for Full-spectrum Coverage: Safinamide in Treating Parkinson’s Disease
• Speaker:  陳柔賢
• Moderator:  林祖功

• 12:50-13:00
• Q&A and Closing
• Speaker:  林祖功
• Moderator: 

2022/8/14, 星期日

• 13:00~13:50
• Lunch symposium-艾拉倫 B Hall
• B Hall (第二會議室) 1F

• Time
• Topic
• Speaker
• Moderator

• 13:00~13:05
• Opening Remark
• Speaker:  謝松蒼
• Moderator: 

• 13:05~13:35
• Acute Hepatic Porphyria (AHP) – Disease Overview, Diagnosis, Management, and Long-term Safety and Efficacy of Givosiran on AHP
• Speaker:  李銘仁
• Moderator:  謝松蒼

• 13:35~13:45
• Q&A
• Speaker:  謝松蒼
• Moderator: 

• 13:45~13:50
• Closing Remark
• Speaker:  謝松蒼
• Moderator: 

2022/8/14, 星期日

• 12:10~13:00
• Lunch symposium-諾華 C Hall
• C Hall (第三會議室) 2F

• Time
• Topic
• Speaker
• Moderator

• 12:10-12:12
• Opening
• Speaker:  蘇真真
• Moderator: 

• 12:12-12:50
• Ofatumumab in MS - the first B-cell therapy in RRMS
• Speaker:  Anneke Van Der Walt
• Moderator:  蘇真真

• 12:50-13:00
• Discussion
• Speaker:  蘇真真
• Moderator: 

2022/8/14, 星期日

• 13:00~13:50
• Lunch symposium-中外製藥 C Hall
• C Hall (第三會議室) 2F

• Time
• Topic
• Speaker
• Moderator

• 13:00~13:05
• Opening
• Speaker:  林志勝
• Moderator: 

• 13:05~13:40
• NMOSD Treatment and ENSPRYNG® (satralizumab) Taiwan Experiences
• Speaker:  郭育呈
• Moderator:  林志勝

• 13:40~13:50
• Discussion
• Speaker:  林志勝
• Moderator: 

2022/8/14, 星期日

• 12:10~13:00
• Lunch symposium-UCB D Hall
• D Hall (第四會議室) 1F

• Time
• Topic
• Speaker
• Moderator

• 12:10-12:15
• Opening
• Speaker:  吳禹利
• Moderator: 

• 12:15-12:50
• Mood, Behavior and Cognition consideration in AED selection
• Speaker:  蔡孟翰
• Moderator:  吳禹利

• 12:50-13:00
• Q&A and Closing
• Speaker:  吳禹利
• Moderator: 

2022/8/14, 星期日

• 13:00~13:50
• Lunch symposium-友華 D Hall
• D Hall (第四會議室) 1F

• Time
• Topic
• Speaker
• Moderator

• 13:35-13:50
• Discussion and closing
• Speaker:  王署君
• Moderator: 

• 13:05-13:35
• Topiramate in the preventive treatment of migraine
• Speaker:  王嚴鋒
• Moderator:  王署君

• 13:00-13:05
• Opening remarks
• Speaker:  王署君
• Moderator: 

2022/8/14, 星期日

• 12:10~13:00
• Lunch symposium-百靈佳 E Hall
• E Hall (第五會議室) 1F

• Time
• Topic
• Speaker
• Moderator

• 12:10~12:15
• Opening
• Speaker:  張永義
• Moderator: 

• 12:15~12:50
• Initiation of pharmacological therapy with dopamine agonist in the treatment of PD, when, why, and how
• Speaker:  林靜嫻
• Moderator:  張永義

• 12:50~13:00
• Panel Discussion and Closing
• Speaker:  張永義
• Moderator: